Save your place

Sign in to WhoBought

Please try again later.

Humacyte, Inc. (HUMA) institutional ownership

Market cap$334M SectorHealthcare
Funds holding · Q1 2026
131
reported HUMA position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
83 buyers · 48 sellers

Humacyte, Inc. (HUMA) price and institutional activity

Dates

Q1 2026

$0 bought by 83 investors
Antipodes Partners LtdGreat Point Partners LLC +81 more
$0 sold by 48 investors
Millennium Management LLCMorgan Stanley +46 more
Sign in to see who bought
Bought Sold Totals per quarter; hover a bar for the names.

Humacyte, Inc. (HUMA) institutional activity · 131

Investor Type Est. change Change Δ Own Date
Antipodes Partners Ltd · Added
Change +5.7M Date Q1 2026
Antipodes Partners Ltd Added· Q1 2026 +5.7M Q1 2026
Great Point Partners LLC · New
Change +3.8M Date Q1 2026
Great Point Partners LLC New· Q1 2026 +3.8M Q1 2026
Millennium Management LLC · Reduced
Change −2.5M Date Q1 2026
Millennium Management LLC Reduced· Q1 2026 −2.5M Q1 2026
Morgan Stanley · Reduced
Change −2.3M Date Q1 2026
Morgan Stanley Reduced· Q1 2026 −2.3M Q1 2026
AQR Capital Management LLC · Added
Change +1.9M Date Q1 2026
AQR Capital Management LLC Added· Q1 2026 +1.9M Q1 2026
Citadel Advisors LLC Exited· Q1 2026 −1.6M −100.0% Q1 2026
Two Sigma Investments, LP · Reduced
Change −1.3M Δ Own −88.1% Date Q1 2026
Two Sigma Investments, LP Reduced· Q1 2026 −1.3M −88.1% Q1 2026
Vanguard · Added
Change +1.2M Date Q1 2026
Vanguard Added· Q1 2026 +1.2M Q1 2026
BNP Paribas Financial Markets · Reduced
Change −1.1M Date Q1 2026
BNP Paribas Financial Markets Reduced· Q1 2026 −1.1M Q1 2026
BlackRock · Added
Change +972K Date Q1 2026
BlackRock Added· Q1 2026 +972K Q1 2026
Barclays PLC · Reduced
Change −689K Date Q1 2026
Barclays PLC Reduced· Q1 2026 −689K Q1 2026
Jane Street Group, LLC · Exited
Change −519K Δ Own −100.0% Date Q1 2026
Jane Street Group, LLC Exited· Q1 2026 −519K −100.0% Q1 2026
Marshall Wace, LLP · Exited
Change −488K Δ Own −100.0% Date Q1 2026
Marshall Wace, LLP Exited· Q1 2026 −488K −100.0% Q1 2026
Squarepoint Ops LLC · Exited
Change −458K Δ Own −100.0% Date Q1 2026
Squarepoint Ops LLC Exited· Q1 2026 −458K −100.0% Q1 2026
Private Advisor Group, LLC · Added
Change +271K Date Q1 2026
Private Advisor Group, LLC Added· Q1 2026 +271K Q1 2026
Data through Q1 2026 · filed Jun 3, 2026
15 of 131

Famous investor activity in Humacyte, Inc. (HUMA)

Humacyte, Inc. (HUMA) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Windham-Bannister Susan Richards · Director Grant (A) 80K
Owned 80K Trade date Jun 11, 2026 Filed date Jun 12, 2026
Windham-Bannister Susan Richards Director Grant (A) 80K 80K Jun 11, 2026 Jun 12, 2026
Constantino Michael T. · Director Grant (A) 80K
Owned 80K Trade date Jun 11, 2026 Filed date Jun 12, 2026
Constantino Michael T. Director Grant (A) 80K 80K Jun 11, 2026 Jun 12, 2026
Wallace Max N. · Director Grant (A) 80K
Owned 80K Trade date Jun 11, 2026 Filed date Jun 12, 2026
Wallace Max N. Director Grant (A) 80K 80K Jun 11, 2026 Jun 12, 2026
Niklason Laura E. · Director Grant (A) 80K
Owned 80K Trade date Jun 11, 2026 Filed date Jun 12, 2026
Niklason Laura E. Director Grant (A) 80K 80K Jun 11, 2026 Jun 12, 2026
Sebelius Kathleen · Director Grant (A) 80K
Owned 80K Trade date Jun 11, 2026 Filed date Jun 12, 2026
Sebelius Kathleen Director Grant (A) 80K 80K Jun 11, 2026 Jun 12, 2026
Jones Keith Anthony · Director Grant (A) 80K
Owned 80K Trade date Jun 11, 2026 Filed date Jun 12, 2026
Jones Keith Anthony Director Grant (A) 80K 80K Jun 11, 2026 Jun 12, 2026
Green Charles Bruce · Director Grant (A) 80K
Owned 80K Trade date Jun 11, 2026 Filed date Jun 12, 2026
Green Charles Bruce Director Grant (A) 80K 80K Jun 11, 2026 Jun 12, 2026
Seimetz Diane · Director Grant (A) 80K
Owned 80K Trade date Jun 11, 2026 Filed date Jun 12, 2026
Seimetz Diane Director Grant (A) 80K 80K Jun 11, 2026 Jun 12, 2026
Bamforth John Philip · Director Grant (A) 80K
Owned 80K Trade date Jun 11, 2026 Filed date Jun 12, 2026
Bamforth John Philip Director Grant (A) 80K 80K Jun 11, 2026 Jun 12, 2026
Brown Emery N. · Director Grant (A) 80K
Owned 80K Trade date Jun 11, 2026 Filed date Jun 12, 2026
Brown Emery N. Director Grant (A) 80K 80K Jun 11, 2026 Jun 12, 2026
Dougan Brady W. · Director Grant (A) 80K
Owned 0 Trade date Jun 11, 2026 Filed date Jun 12, 2026
Dougan Brady W. Director Grant (A) 80K 0 Jun 11, 2026 Jun 12, 2026
Sebelius Kathleen · Director Buy +$50K
Price $0.88 Qty +57K Owned 148K Trade date May 19, 2026 Filed date May 20, 2026
Sebelius Kathleen Director Buy $0.88 +57K +$50K 148K May 19, 2026 May 20, 2026
Constantino Michael T. · Director Buy +$10K
Price $0.89 Qty +11K Owned 44K Trade date May 18, 2026 Filed date May 20, 2026
Constantino Michael T. Director Buy $0.89 +11K +$10K 44K May 18, 2026 May 20, 2026
Sander Dale A. · Officer Sell −$41K
Price $0.90 Qty −46K Owned 267K Trade date May 18, 2026 Filed date May 20, 2026
Sander Dale A. Officer Sell $0.90 −46K −$41K 267K May 18, 2026 May 20, 2026
Parikh Shamik J. · Officer Sell −$41K
Price $0.90 Qty −46K Owned 273K Trade date May 18, 2026 Filed date May 20, 2026
Parikh Shamik J. Officer Sell $0.90 −46K −$41K 273K May 18, 2026 May 20, 2026
15 of 25
15 of 25 Sign in to continue to older insider transactions.

Humacyte, Inc. (HUMA) activist and large shareholders

What are Schedules 13D and 13G?

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Fresenius Medical Care Holdings Inc 18.3M
% of shares outstanding 14.2% Filing date Nov 18, 2024
Fresenius Medical Care Holdings Inc 18.3M 14.2% Nov 18, 2024
Ptc Trustees Gy Ltd AS Trustee of the Gyf Trust 8.9M
% of shares outstanding 8.7% Filing date Sep 8, 2021
Ptc Trustees Gy Ltd AS Trustee of the Gyf Trust 8.9M 8.7% Sep 8, 2021
Blackrock, Inc. 7.5M
% of shares outstanding 6.3% Filing date Nov 8, 2024
Blackrock, Inc. 7.5M 6.3% Nov 8, 2024
Niklason Laura E 6.0M
% of shares outstanding 4.6% Filing date Nov 20, 2024
Niklason Laura E 6.0M 4.6% Nov 20, 2024
M.h. Davidson & Co. 233K
% of shares outstanding 0.1% Filing date Jun 22, 2026
M.h. Davidson & Co. 233K 0.1% Jun 22, 2026
Glazer Capital, LLC
% of shares outstanding 0.0% Filing date Feb 14, 2022
Glazer Capital, LLC 0.0% Feb 14, 2022
Parian Global Management LP
% of shares outstanding 0.0% Filing date Feb 9, 2022
Parian Global Management LP 0.0% Feb 9, 2022
7 of 7

Humacyte, Inc. (HUMA) ownership FAQ

Who owns HUMA?

131 reporting institutions disclosed HUMA position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.